Literature DB >> 14716597

QT variability.

Ronald D Berger1.   

Abstract

We hypothesized that temporal lability in ventricular repolarization is a marker for, and is mechanistically related to, increased risk of malignant ventricular arrhythmias. To assess repolarization lability in the surface electrocardiogram, we developed an automated algorithm, based on template matching, to measure beat-to-beat changes in QT interval. We calculate a QT variability index (QTVI) to quantify the relative magnitude of QT interval changes compared to heart rate variability. We found that QTVI is a reproducible measure. It is elevated in patients with ischemic and nonischemic dilated cardiomyopathy compared with age-matched controls (P<.00001). We have also shown that QTVI is elevated in patients with malignant beta-myosin heavy-chain mutations associated with hypertrophic cardiomyopathy. In a study of patients undergoing electrophysiologic testing, QTVI identified patients with cardiac arrest better than electrophysiologic test result and better than other risk stratifiers included in the analysis. QT variability is a marker of electrical disease in the ventricle and may be associated with enhanced risk of life-threatening arrhythmias.

Entities:  

Mesh:

Year:  2003        PMID: 14716597     DOI: 10.1016/j.jelectrocard.2003.09.019

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  17 in total

1.  QT interval variability in familial Mediterranean fever: a study in colchicine-responsive and colchicine-resistant patients.

Authors:  Udi Nussinovitch; Keren Kaminer; Moshe Nussinovitch; Benjamin Volovitz; Merav Lidar; Naomi Nussinovitch; Avi Livneh
Journal:  Clin Rheumatol       Date:  2012-01-25       Impact factor: 2.980

2.  Relation between beat-to-beat QT interval variability and T-wave amplitude in healthy subjects.

Authors:  Muhammad A Hasan; Derek Abbott; Mathias Baumert
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-07       Impact factor: 1.468

3.  Ventricular repolarization lability in children with Kawasaki disease.

Authors:  Marina Kuriki; Masayuki Fujino; Ken-ichi Tanaka; Kayo Horio; Hirofumi Kusuki; Misa Hosoi; Yoshihiko Eryu; Tomochika Kato; Toshio Yamazaki; Tadayoshi Hata
Journal:  Pediatr Cardiol       Date:  2011-02-23       Impact factor: 1.655

4.  Failure in short-term prediction of ventricular tachycardia and ventricular fibrillation from continuous electrocardiogram in intensive care unit patients.

Authors:  Molly Sachdev; Barry J Fetics; Shenghan Lai; Darshan Dalal; Jerald Insel; Ronald D Berger
Journal:  J Electrocardiol       Date:  2010-04-07       Impact factor: 1.438

Review 5.  Cardiac ventricular repolarization reserve: a principle for understanding drug-related proarrhythmic risk.

Authors:  András Varró; István Baczkó
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

Review 6.  Minimizing repolarization-related proarrhythmic risk in drug development and clinical practice.

Authors:  Attila S Farkas; Stanley Nattel
Journal:  Drugs       Date:  2010-03-26       Impact factor: 9.546

7.  Relationship between beat-to-beat variability of RT-peak and RT-end intervals in normal controls, patients with anxiety, and patients with cardiovascular disease.

Authors:  Vikram Kumar Yeragani; Ronald Berger; Nagaraj Desai; Karl Juergen Bar; Pratap Chokka; Manuel Tancer
Journal:  Ann Noninvasive Electrocardiol       Date:  2007-07       Impact factor: 1.468

8.  Beat-to-beat QT interval dynamics and variability in familial dysautonomia.

Authors:  Udi Nussinovitch; Uriel Katz; Moshe Nussinovitch; Naomi Nussinovitch
Journal:  Pediatr Cardiol       Date:  2009-11-14       Impact factor: 1.655

9.  Mitochondrial ROS Drive Sudden Cardiac Death and Chronic Proteome Remodeling in Heart Failure.

Authors:  Swati Dey; Deeptankar DeMazumder; Agnieszka Sidor; D Brian Foster; Brian O'Rourke
Journal:  Circ Res       Date:  2018-06-13       Impact factor: 17.367

10.  QT variability index in patients with systemic sclerosis.

Authors:  Udi Nussinovitch; Shiri Rubin; Yair Levy; Merav Lidar; Avi Livneh
Journal:  Eur J Rheumatol       Date:  2018-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.